Cover

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

CMS Issues Reimbursement Ruling for Abbott Vascular’s MitraClip Device

 

August 3, 2016—Abbott Vascular announced that the Centers for Medicare & Medicaid Services (CMS) finalized and published its ruling for reimbursement for the company’s MitraClip transcatheter mitral valve repair system. The ruling reassigns MitraClip procedures to diagnosis-related groups 228–229 “Other Cardiothoracic Procedures, with and without major complications or comorbidities (MCCs)” and allows Medicare patients who may benefit from MitraClip to have broader access to the device. The ruling is published and available online in the Federal Register.

In October 2013, the MitraClip received US Food and Drug Administration approval for the treatment of patients with significant symptomatic degenerative mitral regurgitation (MR) who are at prohibitive risk for mitral valve surgery.

Abbott Vascular noted that in August 2014, CMS issued a National Coverage Determination, approval for a New Technology Add-on Payment, and physician reimbursement. Now, Medicare Severity Diagnosis-Related Group reassignment will make hospital MitraClip programs sustainable and demonstrates the government’s commitment to access to innovation for seniors and others in the Medicare program, stated Abbott Vascular.

The MitraClip clip-delivery system is indicated for the percutaneous reduction of significant symptomatic MR (MR ≥ 3+) due to primary abnormality of the mitral apparatus (degenerative MR) in patients in whom existing comorbidities would not preclude the expected benefit from reduced MR and those determined to be at prohibitive risk for mitral valve surgery by a heart team.

The percutaneous MitraClip procedure is a performed as a beating-heart procedure with no cardiopulmonary bypass required. It allows for real-time positioning and repositioning to optimize MR reduction and is designed to preserve surgical options, stated the company.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.